Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug

Heart

Volumn 75, Issue 2, 1996, Pages 165-170

  Aizawa, Yoshifusa ^a   Chinushi, Masaomi ^a   Naitoh, Naoki ^a   Shibata, Akira ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Class I antiarrhythmic drug; Ventricular tachycardia; Zone of entrainment

Indexed keywords

CIBENZOLINE; MEXILETINE; PROCAINAMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ELECTROPHYSIOLOGY; FEMALE; HEART EXCITATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; REENTRY TACHYCARDIA;

EID: 0030046317     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.75.2.165     Document Type: Article

References (36)

1. Waldo AL, Henthorn RW, Plumb VJ, MacLean WAH. Demonstration of the mechanism of transient entrainment and interruption of ventricular tachycardia with rapid arrial pacing. J Am Coll Cardiol 1984;3:422-30.
2. Okumura K, Olshansky B, Henthorn RW, Epstein AE, Plumb VJ, Waldo AL. Demonstration of the presence of slow conduction during sustained ventricular tachycardia in man: use of entrainment of the tachycardia. Circulation 1987;75:369-78.
3. Aizawa Y, Ebe K, Shibata A. Conduction through the reentrant circuit in recurrent sustained ventricular tachycardia evaluated by transient entrainment. Jpn Cir J 1990; 54:1113-21.
4. Kay GN, Epstein AE, Plumb VJ. Resetting of ventricular tachycardia by single extrastimuli. Relation to slow conduction within the reentrant circuit. Circulation 1993;81:1507-19.
5. Aizawa M, Aizawa Y, Chinushi M, Takahashi K, Shibata A. Conductive property of the zone of slow conduction of reentrant ventricular tachycardia and its relation to pacing induced terminability. PACE 1993;17:46-55.
6. Almendral JM, Stamato NJ, Rosenthal ME, Marchlinski FE, Miller JM, Josephson ME. Resetting response patterns during sustained ventricular tachycardia: relationship to the excitable gap. Circulation 1986;74:722-30.
7. Fisher JD, Cohen HL, Mehra R, Altshuler H, Escher DJW, Furman S. Cardiac pacing and pacemakers II: Serial electrophysiologic-pharmacologic testing for control of recurrent sustained ventricular tachyarrhythmias. Am Heart J 1977;93:658-68.
8. Horowitz LN, Josephson ME. Intracardiac electrophysiologic studies as a method for optimization of drug therapy in chronic ventricular tachycardia. Prog Cardiovasc Dis 1980;23:81-98.
9. Aizawa Y, Niwano S, Chinushi M, Tamura M, Kusano Y, Miyajima T, et al. Incidence and mechanism of interruption of reentrant ventricular tachycardia with rapid ventricular pacing. Circulation 1992;85:589-95.
10. Aizawa Y, Tanabe Y, Naitoh N, Washizuka T, Shibata A, Josephson ME. Procainamide-induced change of the width of the zone of entrainment and its relation to the inducihility of reentrant ventricular tachycardia. Jpn Heart J 1994;35:611-23.
11. Vaughan-Williams EM. Classification of antidysrhythmic drugs. In: Sandoe E, Flensted-Jensen E, Olsen HK, eds. Symposium on cardiac arrhythmias. Sodertalji, Sweden: AB Astra, 1970;449-72.
12. Fontaine G, Guiraudon G, Frank R. Surgical treatment of ventricular tachycardia unrelated to myocardial infarction. Am J Cardiol 1982;49:397-410.
13. Wellens HJJ. Value and limitations of programmed electrical stimulation in ventricular tachycardia. Circulation 1978; 57:845-53.
14. Josephson ME, Horowitz LN, Farshidi A, Kastor JA. Recurrent sustained ventricular tachycardia. I. Mechanism. Circulation 1978;57:431-40.
15. Josephson ME, Horowitz LN, Spielman SR, Greenspan AM. Role of catheter mapping in the preoperative evaluation of ventricular tachycardia. Am J Cardiol 1982;49: 207-10.
16. Marchlinski FE, Buxton AE, Vassallo JA, Waxman HL, Cassidy DM, Doherty JU, et al. (Comparative electrophysiologic effects of intravenous and oral procainamide in patients with sustained ventricular arrhythmias. J Am Coll Cardiol 1984;4:1247-54.
17. Morady F, Kou WH, Schmaltz S, Annesley T, Buitler MD, Nelson SD. Pharmacodynamics of intravenous procainamide as used during acute electropharmacologic testing. Am J Cardiol 1988;61:93-8.
18. Gillis AM, Wyse DG, Duff HJ, Mitchel LB. Drug response at electro physio logic study in patients with ventricular tachyarrhythmias: The importance of ventricular refractoriness. J Am Coll Cardiol 1991;17:914-20.
19. Spielman SR, Schwartz JS, McCarthy DM. Predictors of the success or failure of medical therapy in patients with chronic recurrent sustained ventricular tachycardia: a discriminative analysis. J Am Coll Cardiol 1983;1:401-8.
20. Kuchar DL, Rottman J, Berger E, Freeman CS, Garan CS, Ruskin JN. Prediction of successful suppression of sustained ventricular tachyarrhythmias by serial drug testing from data derived at the initial electrophysiologic study. J Am Coll Cardiol 1988;12:982-8.
21. Furukawa T, Rozanski JJ, Moroe K, Goselin AJ, Lister JW. Efficacy of procainamide on ventricular tachycardia: relation to prolongation of refractoriness and slowing of conduction. Am Heart J 1989;118:702-8.
22. Waxman HL, Buxton AH, Sadowski LM, Josephson ME. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications. Circulation 1982,67: 30-7.
23. Kus T, Costi P, Dubuc M, Shensa M. Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction. Am Heart J 1990;120:855-63.
24. Gold RL, Haffajee CI, Alpert JS. Electrophysiologic and clinical factors influencing response to class IA antiarrhythmic agents in patients with inducible sustained monomorphic ventricular tachycardia. Am Heart J 1986; 112:9-13.
25. Schmitt CG, Kadish AH, Marchlinski FE, Miller JA, Buxton AE, Josephson ME. Effects of lidocaine and procainamide on normal and abnormal intraventricular electrograms during sinus rhythm. Circulation 1988;77: 1030-37.
26. Kay GN, Epstein AH, Plumb VJ. Preferential action of procainamide on the reentrant circuit of ventricular tachycardia. J Am Coll Cardiol 1989;14:382-90.
27. Aizawa Y, Funazaki T, Ebe K, Niwano S, Tamura M, Chinushi M, et al. Quantitative evaluation of antiarrhythmic agents on the reentrant circuit of ventricular tachycardia. Jpn J Electrocardiol 1991;11:249-57.
28. Inoue H, Yamashita T, Nozaki A, Sugimoto T. Effects of antiarrhythmic drugs on canine atrial flutter due to reentry: role of prolongation of refractory period and depression of conduction to excitable gap. J Am Coll Cardiol 1991;18:1098-104.
29. The Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian Gambit. Eur Heart J 1991,12:1112-31.
30. Hondeghem LM, Katzung BG. Antiarrhythmic agents: The modulated receptor mechanism of action of sodium and calcium blocking drugs. Ann Rev Pharmacol Toxicol 1984;24:387-423.
31. Grant AO, Starmer CF, Strauss HC. Antiarrhythmic drug action. Blockade of the sodium inward current. Circ Res 1984;55:427-39.
32. Stamato NJ, Rosenthal ME, Almendral JM, Josephson ME. The resetting response of ventricular tachycardia to single and double extrastimuli: implications for an excitable gap. Am J Cardiol 1987;60:596-601.
33. Almendral JM, Rosenthal MH, Stamato NJ, Marchlinski FE, Buxton AH, Frame LH, et al. Analysis of the resetting phenomenon in sustained uniform ventricular tachycardia: Incidence and relation to termination. J Am Coll Cardiol 1986;8:294-300.
34. Naccarelli GV, Zipes PP, Rahilly GT, Heger JJ, Prystowsky EN. Influence of tachycardia cycle length and antiarrhythmic drugs on pacing termination and acceleration of ventricular tachycardia. Am Heart J 198 3; 105:1-5.
35. Josephson ME. Recurrent sustained ventricular tachycardia. In: Josephson ME, ed. Clinical cardiac electrophysiology. Technique and Interpretation. Philadelphia: Lea & Febiger, 1993;417-615.
36. Brugada P, Boersma L, Abdollah H, Kirchhof C, Allessie M. Echo-wave termination of ventricular tachycardia. A common mechanism of termination of reentrant arrhythmias by various pharmacological interventions. Circulation 1992;85:1879-87